[1]缪晓辉.隐源性肝炎诊治方面的若干问题[J].肝脏, 2002, 6 (2) ∶74~78.
|
[2]Honarkar Z, Alavian SM, Samiee, et al.Occult hepatitis B amongchronic liver disease patients[J].Saudi Med J, 2005, 26 (4) ∶601~606.
|
[3]Ergunay K.Occult hepatitis B infection[J].Mikrobiyol Bul, 2005, 39 (2) ∶241~249.
|
[4]Pollicino T, Squadrito G, Cerenzia G, et al.Hepatitis B virus main-tains its proonCogenic properties in case of occult HBVinfection[J].Gastroenterology, 2004, 126∶102~110.
|
[5]Uchida T, Saitoh T, Shinzawa H.Mutations of the X region of hepa-titis B virus and their clinical implications[J].Pathol Int, 1997, 47∶183~193.
|
[6]Toyoda H, Hayashi K, Murakami Y, et al.Prevalence and clinicalimplications of occult hepatitis B viral infection in hemophilia patientsin Japan[J].J Med Virol, 2004, 73∶195~199.
|
[7]周国平, 白敬羽, 李夏亭, 等.乙型肝炎病毒X区核苷酸序列变异的检测[J].中华传染病杂志, 2003, 21 (1) ∶33~35.
|
[8]Raimondo G, Pollicino T, Squadrito G.What is the clinical impactof occult hepatitis B virus infection?[J].Lancet, 2005, 365 (9460) ∶638~140.
|
[9]Anwar W, Sarwar M, Hussain AB, et al.Significance of occult HBVinfection in patients with chronic hepatitis C[J].J Coll PhysiciansSurg Pak, 2006, 16 (3) ∶192~195.
|
[10]Squdrito G, Squadrito G, Pollicino T, et al.Occult hepatitis B vi-rus infection is ssociated with the development of hepatocellular carci-noma in chronic hepatitis C patients[J].Cancer, 2006, 106 (6) ∶1326~1330.
|
[11]Tabor E.Infections by hepatitis B surface antigen gene mutants inEurope and North America[J].J Med Virol, 2006, 78 Suppl 1∶S43~47.
|
[12] 庄辉, 李奎, 朱万孚, 等.血清学阴性的病毒型肝炎病原学研究[J].中华内科杂志, 2000, 39∶801~804.
|
[13]Chemin I, Jeantet D, Kay A, et al.Role of hepatitis B virus inchronic hepatitis B surface antigen (-) liver disease[J].AtiviralRes, 2001, 52∶117~123.
|
[1] | Chinese Society of Hepatology, Chinese Medical Association. Consensus on the management of hepatitis B virus infection in women of childbearing age[J]. Journal of Clinical Hepatology, 2018, 34(6): 1176-1180. doi: 10.3969/j.issn.1001-5256.2018.06.008 |
[2] | Zhu FuSheng, Qin YuJie, Cheng ZhenJiang, Jiang PeiRong, Zhang LingHui. The impact of HBV/HCV coinfection on HBV DNA levels and the severity of liver diseases in HBV-infected patients undergoing hemodialysis[J]. Journal of Clinical Hepatology, 2013, 29(2): 136-137+141. |
[3] | Li JinE, Chen XinYue. Recent progress in research of hepatitis B viruses with precore and basic core promoter mutations[J]. Journal of Clinical Hepatology, 2013, 29(2): 88-92. doi: |
[4] | Xu XiuHua, Xiang XiaoXing, Long AiHua, Liu Dan, Wang JingSong. Differential distribution of age and HBV serological markers in liver cirrhosis and non-cirrhotic patients with primary liver cancer[J]. Journal of Clinical Hepatology, 2013, 29(3): 214-216. |
[5] | Cao Xiao, Cao QingBao, Zhang GuoQiang, Chang ZaiJuan, Li ShuPing, Xu WeiWei. Analysis of occult hepatitis B virus infection among blood donors in Tangshan, China[J]. Journal of Clinical Hepatology, 2013, 29(2): 117-119. |
[6] | Zhang JianJun, Wu LiPing, Du RuiQing, Wang JianBin, Yao ZhanCheng, Yu GuiQin. Factors correlating with the liver inflammation grade ≥G2 in chronic HBV-infected patients with normal liver function[J]. Journal of Clinical Hepatology, 2012, 28(1): 35-38. |
[7] | Wang YuMing, Cheng Lin. Recent perspectives of Chinese medicine-based therapy for hepatitis B and C virus infection[J]. Journal of Clinical Hepatology, 2012, 28(11): 872-876. |
[8] | Liu Cheng, Mu YongPing, Yang ZongGuo, Chen XiaoRong. Clinical significance of monitoring hepatitis B virus core-related antigens [J]. Journal of Clinical Hepatology, 2012, 28(10): 793-796. |
[9] | Peng JianPing, Sun KeWei, Wu YuNan. Impact of early virological response to antiviral treatment on the outcomes of hepatitis B-associated liver failure [J]. Journal of Clinical Hepatology, 2012, 28(10): 752-755. |
[10] | Hu XiaoLi, Zhao HongWei, Wu XiaoYan, Niu JunQi. Prevalence of hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2012, 28(6): 413-416+421. |
[11] | Zhang XinXin. The hepatitis B virus heterogeneity and the anti-viral response[J]. Journal of Clinical Hepatology, 2011, 27(12): 1262-1265. |
[12] | Chen Wei, Ding Yang, Sheng QiuJu, Dou XiaoGuang. HBV mother-to-child transmission block-agreement and controversy[J]. Journal of Clinical Hepatology, 2011, 27(12): 1259-1261. |
[13] | Zou XiaoJing, Jiang XueQiang, Tian DeYing. Role of DC-SIGN on the maturation and activation of dendritic cells in chronic hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2011, 27(2): 145-147+153. |
[14] | Ni Wei, Shi WeiQun. Clinical diagnosis and liver biopsy diagnosis of 97 cases with chronic HBV infection[J]. Journal of Clinical Hepatology, 2011, 27(6): 623-624+637. |
[15] | Xiong QiXiang, Xiong LiJuan. Hepatitis B virus infection and DNA methylation in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2011, 27(8): 881-884. |
[16] | Gao Zhen, Zhang LunLi. Toll like receptors mediated innate immune responses against HBV infection[J]. Journal of Clinical Hepatology, 2011, 27(6): 667-669+673. |
[17] | Yuan JianGuo, Wang XinGuo, Cui Xia, Liu FengHua, Wang FengHua, Song JiKui, Zhao HongKui. The activation of rat hepatic stellate cells stimulated with hepatitis B virus in vitro[J]. Journal of Clinical Hepatology, 2011, 27(2): 163-165. |
[18] | Wang ChunYan, Li Bing. One case of congenital hepatic fibrosis and hepatitis B virus infection and drug-induced liver injury[J]. Journal of Clinical Hepatology, 2011, 27(12): 1318-1319. |
[19] | Shi YanMei, Lan YingHua, Dan Lei, Zhou Jin, Li YongGuo. The relationship between of hematopoietic stem cells and hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2010, 26(4): 377-380. |
[20] | Wang XiaoLin, Yang Jing. Occult hepatitis B virus infection [J]. Journal of Clinical Hepatology, 2009, 25(1): 67-69. |